Webinar
Contents
Chair(s)

Prof. Stefano Omboni
Clinical Research Unit, Italian Institute of Telemedicine, Varese, Italy.
Department of Cardiology, Sechenov First Moscow State Medical University, Moscow, Russian Federation.
Department of Cardiology, Sechenov First Moscow State Medical University, Moscow, Russian Federation.

Dr. Anastasia Susie Mihailidou
Department of Cardiology, Royal North Shore Hospital & Kolling Institute, Sydney, Australia.
Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia.
Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia.
Speaker(s)

Prof. Nadia Khan
Department of Medicine, The University of British Columbia, Vancouver, Canada.

Dr. Shariful Islam
Deakin University, Geelong, Australia.

Prof. Philippe Ryvlin
Department of Clinical Neuroscience, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.

Dr. Lisa McCann
University of Strathclyde, Glasgow, United Kingdom.
Programme
Programme
- Time (GMT+2)
- Chairs/Speakers
- Topic
- 2:00 PM
- Stefano Omboni
- Welcome Speech
- 2.05-2.15 PM
- Nadia Khan
- Virtual Management of Arterial Hypertension
- 2:10-2:20 PM
- Shariful Islam
- Digital Health in the Management of Cardiovascular and Metabolic Diseases
- 2:20-2:30 PM
- Philippe Ryvlin
- Digital Health in the Management of Neurological Diseases
- 2:30-2:40 PM
- Lisa McCann
- Real-time Remote Monitoring Systems for Patients with Cancer
- 2:40-2:55 PM
- Stefano Omboni / Anastasia Susie Mihailidou
- General Discussion (Q&A)
- 2.55-3.00 PM
- Assistant Editor
- Journal Presentation
- 3:00 PM
- Stefano Omboni / Anastasia Susie Mihailidou
- Concluding Remarks
Presentation

Dr. Lisa McCann
Topic: Real-time Remote Monitoring Systems for Patients with Cancer
NaN

Prof. Nadia Khan
Topic: Virtual Management of Arterial Hypertension
NaN

Dr. Shariful Islam
Topic: Digital Health in the Management of Cardiovascular and Metabolic Diseases
NaN

Prof. Philippe Ryvlin
Topic: Digital Health in the Management of Neurological Diseases
NaN

General Discussion (Q&A)
NaN